Primary Site >> Colorectal Cancer
Gene >> CREM
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|
|
Ref: Chemoprevention of colorectal cancer by aspirin: a cost-effectiveness analysis. PMID: 11781283 |
Ref: Transfection of K-rasAsp12 cDNA markedly elevates IL-1beta- and lipopolysaccharide-mediated inducible nitric oxide synthase expression in rat intestinal epithelial cells. PMID: 14576830 |
Ref: PMID: 20722142 |
Ref: Surveillance colonoscopy is cost-effective for patients with adenomas who are at high risk of colorectal cancer. PMID: 20226186 |
Ref: Cost effectiveness and projected national impact of colorectal cancer screening in France. PMID: 21623557 |
Ref: Analisis de Costo-Efectividad de las Estrategias de Tamizacion de Cancer Colorrectal en Colombia. PMID: 29702900 |
Ref: Gene signature distinguishes patients with chronic ulcerative colitis harboring remote neoplastic lesions. PMID: 23388545 Ref: The Myb-p300-CREB axis modulates intestine homeostasis, radiosensitivity and tumorigenesis. PMID: 23618903 Ref: Breakpoint analysis of transcriptional and genomic profiles uncovers novel gene fusions spanning multiple human cancer types. PMID: 23637631 |
Ref: Long-term health outcomes and cost-effectiveness of a computer-tailored physical activity intervention among people aged over fifty: modelling the results of a randomized controlled trial. PMID: 25342517 |
Ref: When is Genomic Testing Cost-Effective? Testing for Lynch Syndrome in Patients with Newly-Diagnosed Colorectal Cancer and Their Relatives. PMID: 26473097 |
Ref: Cost-effectiveness of routine screening for Lynch syndrome in colorectal cancer patients up to 70 years of age. PMID: 26938782 Ref: Cost-effectiveness of routine screening for Lynch syndrome in endometrial cancer patients up to 70years of age. PMID: 27789085 |